Health, Fitness & Food

Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just in time for the last hour of trading on Wall Street. Market slides : The S & P 500 gave back earlier gains and fell throughout Tuesday afternoon, led lower by the mega-cap tech stocks. Ahead of the

In this article 4523.T-JP Follow your favorite stocksCREATE FREE ACCOUNT The newly FDA approved Alzheimer’s treatment Leqembi is prepared at Abington Neurological Associates in Abington, PA., on Tuesday, November 7, 2023.  Hannah Yoon | The Washington Post | Getty Images The breakthrough Alzheimer’s drug Leqembi slowed disease progression in patients over three years, demonstrating the

In this article AAPL Follow your favorite stocksCREATE FREE ACCOUNT Mark uses the Vision Pro with his BCI Courtesy of Synchron Neurotech startup Synchron on Tuesday announced it has connected its brain implant to Apple‘s Vision Pro headset. It’s now possible for patients with limited physical mobility to control the device using only their thoughts. 

Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just in time for the last hour of trading on Wall Street. Market moves: The S & P 500 was on track for small gains following a solid rally last Friday. There’s still some market rotation happening, but

We’re making four trades Monday morning. Shortly after the opening bell, we will be selling 100 shares of Danaher at roughly $274.13. Following the trade, Jim Cramer’s Charitable Trust will own 475 shares of Danaher, decreasing its weighting in the portfolio to 4% from 4.84%. In addition, we will be selling 20 shares of Salesforce at

Fruit bats seen hanging on tree branches in daylight. Bats are believed to be one of the carriers of Nipah virus, a zoonotic disease that spreads from animals to humans. Eyepix Group | Future Publishing | Getty Images Health authorities in the southern Indian state of Kerala are on high alert following the latest flare-up of the

In this article AMZN GEHC Follow your favorite stocksCREATE FREE ACCOUNT Jakub Porzycki | Nurphoto | Getty Images GE HealthCare on Thursday announced it is teaming up with Amazon Web Services to build new generative artificial intelligence models and tools that can efficiently analyze complex medical data. The health-care industry is responsible for generating nearly

In this article BMY Follow your favorite stocksCREATE FREE ACCOUNT The Bristol Myers Squibb research and development center at Cambridge Crossing in Cambridge, Massachusetts, on Dec. 27, 2023. Adam Glanzman | Bloomberg | Getty Images Bristol Myers Squibb on Friday reported second-quarter earnings and revenue that topped expectations and raised its full-year guidance as the

Every weekday the CNBC Investing Club with Jim Cramer holds a “Morning Meeting” livestream at 10:20 a.m. ET. Here’s a recap of Friday’s key moments. Stocks jumped Friday as Wall Street tried to end a turbulent week on a jubilant note. The Dow Jones Industrial Average added more more than 600 points, or 1.6%. The

Kevin Sayer, CEO, Dexcom Scott Mlyn | CNBC Dexcom shares sank more than 40% on Friday and headed for their worst day ever after the diabetes management company reported disappointing revenue for the second quarter and offered weak guidance. The stock fell $45.38 to $62.47 as of early afternoon, wiping out about $18 billion in

In this article 4523.T-JP BIIB Follow your favorite stocksCREATE FREE ACCOUNT Eisai | via Reuters European drug regulators on Friday rejected the Alzheimer’s treatment Leqembi from Biogen and Eisai, creating another hurdle for the companies as they scramble to boost uptake of the therapy in the U.S.  The European Commission, the EU’s executive body, has

In this article DXCM Follow your favorite stocksCREATE FREE ACCOUNT The Dexcom logo is seen on a smartphone screen and in the background. Pavlo Gonchar | SOPA Images | Lightrocket | Getty Images Shares of Dexcom tumbled more than 35% in extended trading Thursday after the diabetes management company reported disappointing revenue for the second

In this article LLY VKTX NOVO.B-DK Follow your favorite stocksCREATE FREE ACCOUNT Weight loss drug concept. Cr | Istock | Getty Images Shares of Viking Therapeutics jumped more than 20% on Thursday after the biotech company a day earlier announced plans to advance its experimental weight loss injection into a late-stage trial earlier than expected. 

In this article SGMO PFE Follow your favorite stocksCREATE FREE ACCOUNT Kena Betancur | Corbis News | Getty Images Pfizer on Wednesday said its experimental gene therapy for a rare genetic blood-clotting disorder succeeded in a large late-stage trial, paving the way for a potential approval. The treatment for hemophilia A could become the company’s

Novo Nordisk’s Wegovy weight loss drug has seen a meteoric rise in popularity.  Nurphoto | Getty Images LONDON — The U.K.’s health regulator on Tuesday approved the use of Novo Nordisk‘s Wegovy weight loss drug to reduce the risk of overweight and obese adults suffering from serious heart problems or strokes. The new approval from

Activists protest the price of prescription drug costs in front of the U.S. Department of Health and Human Services building in Washington, D.C., on Oct. 6, 2022. Anna Moneymaker | Getty Images Think a friend or colleague should be getting this newsletter? Share this link with them to sign up. Good afternoon! The first round

In this article GOOGL META Follow your favorite stocksCREATE FREE ACCOUNT Hands, tablet and doctor with body hologram, overlay and dna research for medical innovation on app. Medic man, nurse and mobile touchscreen for typing on anatomy study or 3d holographic ux in clinic Jacob Wackerhausen | Istock | Getty Images Dr. Scott Gottlieb is

In this article UNH NOVO.B-DK LLY Follow your favorite stocksCREATE FREE ACCOUNT A box of Ozempic made by Novo Nordisk is seen at a pharmacy in London, Britain March 8, 2024. Hollie Adams | Reuters Think a friend or colleague should be getting this newsletter? Share this link with them to sign up. Good morning!

Photo: Jaromir Chalabala / Getty LONDON — The evidence linking smartphone use with mental health harms in children is growing and one grassroots organization in the U.K. is supporting parents who are refraining from giving their kids the devices. Smartphone Free Childhood, founded by Daisy Greenwell and Clare Fernyhough in February, set up various group

Mark using Synchron’s BCI  Courtesy: Synchron A 64-year-old named Mark has spent the last year learning how to control devices like his laptop and phone using a brain implant. And thanks to OpenAI, it’s gotten a whole lot easier to do.  The neurotech startup Synchron said Thursday it’s using OpenAI’s latest artificial intelligence models to